Scheme

UTI Healthcare Fund - Regular Plan - IDCW

UTI Mutual Fund · Equity Scheme - Sectoral/ ThematicNAV 256.9262 on 03 Nov 20261Y 13.25%3Y 22.31%5Y 15.19%

All funds

Factsheet

As of 31 Aug 2026

Inception
28 Jun 1999
Fund managers
Mr. Kamal Gada
Benchmark
BSE Healthcare TRI
AUM
1443.57 crore
Regular expense
2.81%
Direct expense
1.77%
Portfolio turnover
0.45
Minimum investment
5000
Exit load
< 30 days – 1%; ≥ 30 days – Nil CAPLin Point 2.7 Industries Ltd Laboratories Ltd Laurus Labs Ltd -4.5 Sharpe Ratio 1.41 Portfolio Turnover
Standard deviation
14.7%
Beta
0.92
Sharpe
1.41

Portfolio

As of 31 Aug 2026

Top 10 holdings

Holding% of net assets
Sun Pharmaceuticals Industries Ltd8.25%
Divis Laboratories Ltd6.21%
Ajanta Pharma Ltd4.74%
Gland Pharma Ltd3.7%
Dr Reddy'S Laboratories Ltd3.62%
Alkem Laboratories Ltd3.29%
Apollo Hospitals Enterprise Ltd3.27%
Max Healthcare Institute Ltd3.1%
Lupin Ltd3.09%
Caplin Point Laboratories Ltd3.05%